# Curated DDI entries; authoritative, manually reviewed
# Fields: drug_primary, drug_interactor, severity, mechanism, recommendation, evidence_source, evidence_level, citations

- drug_primary: capecitabine
  drug_interactor: warfarin
  severity: major
  mechanism: Increased anticoagulant effect (INR elevation)
  recommendation: monitor
  evidence_source: label
  evidence_level: high
  citations:
    - source_type: label
      url: https://www.accessdata.fda.gov
      snippet: Capecitabine increases anticoagulant effect of warfarin; monitor INR.

- drug_primary: tamoxifen
  drug_interactor: paroxetine
  severity: major
  mechanism: CYP2D6 inhibition reduces endoxifen
  recommendation: avoid
  evidence_source: guideline
  evidence_level: high
  citations:
    - source_type: guideline
      id: CPIC-Tamoxifen-CYP2D6
      url: https://cpicpgx.org/guidelines/guideline-for-tamoxifen-and-cyp2d6/
      snippet: Avoid strong CYP2D6 inhibitors with tamoxifen.
